We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing

News   Mar 10, 2017 | Original Story from ImmunoMet

 
ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing
 
 
 

RELATED ARTICLES

Temperature-stable Tuberculosis Vaccine Enters Clinical Testing

News

Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis vaccine candidate.

READ MORE

New Vaccine Offers Fresh Take On Malaria Fight

News

This new vaccine reduced the malaria-causing parasite’s release from the liver and into the blood of infected rhesus macaques by 75 to 80 percent at the Oregon National Primate Research Center at OHSU.

READ MORE

Vocabulary of Immune Cells Extended by Protein Engineering

News

Researchers around the world are on the search for new therapies – so far in vain. An interdisciplinary team from the fields of structural biology, immunology and cell biology has now, for the first time, successfully produced a protein that could balance the overshooting immune response.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE